COVID-19 vaccine ‘Covaxin’ marks a significant milestone: Karnataka Health Minister

▴ COVID-19 vaccine ‘Covaxin’ marks a significant milestone: Karnataka Health Minister
Karnataka Minister for Health and Medical Education Dr. K. Sudhakar has come forward to negate suspicion on the Covaxin vaccine developed by Bharat Biotech.

Karnataka Minister for Health and Medical Education Dr. K. Sudhakar has come forward to negate suspicion on the Covaxin vaccine developed by Bharat Biotech.

He has appeared as a fellow medical professional to refrain from unwarranted criticism discrediting the hard work of the scientists involved in the development of the vaccine within the country.
 
In a series of tweets today, the Minister said that the COVID-19 vaccine Covaxin developed within the country marks a significant milestone. He said that India being one of the largest exporters of vaccines and the world is looking up to India in the common fight against the global pandemic.

The Minister stressed that Bharat Biotech is a globally reputed company with the credibility and experience of developing 16 vaccines including for influenza H1N1, Rotavirus, Japanese Encephalitis, Rabies, Chikungunya, Zika, and the world’s first tetanus-toxoid conjugated vaccine for Typhoid.

 
Dr. Sudhakar informed that Bharat Biotech has delivered over four billion vaccine doses to the underprivileged people in more than 150 developing countries through UNICEF and other channels.

On the clinical trials of Covaxin, the Minister said, the Phase-3 clinical trial involves 24,000 volunteers and its data will be available soon

Tags : #KarnatakasCovid-19Update05Jan2021 #Karnataka #India #HealthandEducationMinister #DrKSudhakar #Covid-19Vaccine #BharatBiotech #Covaxin #VaccineForCovidTreatment #VaccineClinicalTrails #FightAgainstCovidVirus

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024